AAAAAA

   
Results: 1-11 |
Results: 11
ERYTHROPOIETIN TREATMENT DECREASES CARDIOVASCULAR MORBIDITY AND MORTALITY IN CAPD PATIENTS
Authors: BAJO MA SELGAS R CASTRO MJ JIMENEZ C FERNANDEZREYES MJ DELPESO G DEALVARO F SANCHEZSICILIA L
Citation: Ma. Bajo et al., ERYTHROPOIETIN TREATMENT DECREASES CARDIOVASCULAR MORBIDITY AND MORTALITY IN CAPD PATIENTS, Peritoneal dialysis international, 17(2), 1997, pp. 129-135
A COMPARATIVE SURVEY ON THE INCIDENCE OF KIDNEY GRAFT PRIMARY VASCULAR THROMBOSIS AMONG CAPD AND HEMODIALYSIS-PATIENTS
Authors: ESCUIN F DELPESO G FONTAN MP RODRIGUEZCARMONA A MARTINEZ A LANUZA M HORTAL L FERNANDEZ AM ALBERO MD CONTRERAS JP SELGAS R
Citation: F. Escuin et al., A COMPARATIVE SURVEY ON THE INCIDENCE OF KIDNEY GRAFT PRIMARY VASCULAR THROMBOSIS AMONG CAPD AND HEMODIALYSIS-PATIENTS, Nephrology, dialysis, transplantation, 11(9), 1996, pp. 1896-1897
MITRAL ANNULAR CALCIFICATION IN CAPD PATIENTS WITH A LOW DEGREE OF HYPERPARATHYROIDISM - AN ANALYSIS OF OTHER POSSIBLE RISK-FACTORS
Authors: FERNANDEZREYES MJ BAJO MA ROBLES P SELGAS R OLIVER J DELPESO G GARCIA G JIMENEZ C GARCIAGALLEGO F
Citation: Mj. Fernandezreyes et al., MITRAL ANNULAR CALCIFICATION IN CAPD PATIENTS WITH A LOW DEGREE OF HYPERPARATHYROIDISM - AN ANALYSIS OF OTHER POSSIBLE RISK-FACTORS, Nephrology, dialysis, transplantation, 10(11), 1995, pp. 2090-2095
INCREASED RESPONSE TO SUBCUTANEOUS ERYTHROPOIETIN ON TYPE-I DIABETIC-PATIENTS ON CAPD - IS THERE A SYNERGISTIC EFFECT WITH INSULIN
Authors: FERNANDEZREYES MJ SELGAS R BAJO MA JIMENEZ C DELPESO G SANCHEZ MDC DAPENA F DEALVARO F
Citation: Mj. Fernandezreyes et al., INCREASED RESPONSE TO SUBCUTANEOUS ERYTHROPOIETIN ON TYPE-I DIABETIC-PATIENTS ON CAPD - IS THERE A SYNERGISTIC EFFECT WITH INSULIN, Peritoneal dialysis international, 15(6), 1995, pp. 231-235
PRESERVING THE PERITONEAL-DIALYSIS MEMBRANE IN LONG-TERM PERITONEAL-DIALYSIS PATIENTS
Authors: SELGAS R BAJO MA DELPESO G JIMENEZ C
Citation: R. Selgas et al., PRESERVING THE PERITONEAL-DIALYSIS MEMBRANE IN LONG-TERM PERITONEAL-DIALYSIS PATIENTS, Seminars in dialysis, 8(6), 1995, pp. 326-332
INCIDENCE, ETHIOLOGY, SIGNIFICANCE AND CONSEQUENCES OF PERITONITIS CAUSED BY GRAM-NEGATIVE BACTERIA ON CAPD - EXPERIENCE OVER A PERIOD OF 13 YEARS AT ONE-CENTER
Authors: JIMENEZ C SELGAS R BAJO MA FERNANDEZREYES MJ DELPESO G GARCIAPEREA A DEALVARO F
Citation: C. Jimenez et al., INCIDENCE, ETHIOLOGY, SIGNIFICANCE AND CONSEQUENCES OF PERITONITIS CAUSED BY GRAM-NEGATIVE BACTERIA ON CAPD - EXPERIENCE OVER A PERIOD OF 13 YEARS AT ONE-CENTER, Nefrologia, 15(1), 1995, pp. 42-49
CLINICAL-SIGNIFICANCE OF EXIT-SITE INFECTIONS DUE TO XANTHOMONAS IN CAPD PATIENTS - A COMPARISON WITH PSEUDOMONAS INFECTION
Authors: DAPENA F SELGAS R GARCIAPEREA A DELPESO G BAJO MA REYES MJF JIMENEZ C SANCHEZ C MUNOZ I DEALVARO F
Citation: F. Dapena et al., CLINICAL-SIGNIFICANCE OF EXIT-SITE INFECTIONS DUE TO XANTHOMONAS IN CAPD PATIENTS - A COMPARISON WITH PSEUDOMONAS INFECTION, Nephrology, dialysis, transplantation, 9(12), 1994, pp. 1774-1777
FUNCTIONAL LONGEVITY OF THE HUMAN PERITONEUM - HOW LONG IS CONTINUOUSPERITONEUM DIALYSIS POSSIBLE - RESULTS OF A PROSPECTIVE MEDIUM LONG-TERM STUDY
Authors: SELGAS R FERNANDEZREYES MJ BOSQUE E BAJO MA BORREGO F JIMENEZ C DELPESO G DEALVARO F
Citation: R. Selgas et al., FUNCTIONAL LONGEVITY OF THE HUMAN PERITONEUM - HOW LONG IS CONTINUOUSPERITONEUM DIALYSIS POSSIBLE - RESULTS OF A PROSPECTIVE MEDIUM LONG-TERM STUDY, American journal of kidney diseases, 23(1), 1994, pp. 64-73
MONCRIEF TECHNIQUE FOR PERITONEAL CATHETE R PLACEMENT - A 3 YEARS EXPERIENCE OF A CAPD CENTER
Authors: ROMERO JR DEALVARO F SELGAS R BAJO MA SERRANO P FERNANDEZREYES MJ DELPESO G JIMENEZ C GARCIA G DAPENA F
Citation: Jr. Romero et al., MONCRIEF TECHNIQUE FOR PERITONEAL CATHETE R PLACEMENT - A 3 YEARS EXPERIENCE OF A CAPD CENTER, Nefrologia, 14(2), 1994, pp. 181-188
LONG-TERM TREATMENT OF ANEMIA IN PREDIALYSIS CHRONIC-RENAL-FAILURE PATIENTS
Authors: ALONSO JLM ARA JM DELPESO G ZAMORANO A
Citation: Jlm. Alonso et al., LONG-TERM TREATMENT OF ANEMIA IN PREDIALYSIS CHRONIC-RENAL-FAILURE PATIENTS, Kidney international, 46(2), 1994, pp. 558-558
ANTI-HEPATITIS-C VIRUS-ANTIBODIES - PREVA LENCE IN PATIENTS UNDER HEMODIALYSIS, FAMILY RELATED AND, NEPHROLOGY STAFF
Authors: JIMENEZ C MIGUEL JL MARTINEZZAPICO R BAJO MA MARTINEZARA J SELGAS R DELPESO G
Citation: C. Jimenez et al., ANTI-HEPATITIS-C VIRUS-ANTIBODIES - PREVA LENCE IN PATIENTS UNDER HEMODIALYSIS, FAMILY RELATED AND, NEPHROLOGY STAFF, Nefrologia, 13(5), 1993, pp. 430-434
Risultati: 1-11 |